Home | Welcome to Contract Pharma   
Last Updated Friday, March 6 2015

Print

Breaking News

Related Searches:
May 27, 2011
Speciality European Pharma (SEP) and SCM Pharma have entered a manufacturing development agreement for the development and validation of the manufacturing and product testing processes at SCM’s UK-based facility.  Read More »
May 27, 2011
Pharmascience, a generic pharmaceutical company basin in Quebec, has acquired Aegera Therapeutics, a Montreal-based clinical-stage biotechnology company focused on developing therapeutics to address unmet medical needs, primarily in oncology.  Read More »
May 27, 2011
Dr. John Talley has been appointed chief scientific officer of SARmont, a provider of medicinal chemistry services.  Read More »
May 26, 2011
Pfizer has selected PAREXEL International and ICON plc as preferred providers for clinical trial services.   Read More »
May 26, 2011
Johnson & Johnson will review growth strategies for its Pharmaceuticals business and address therapeutic area strategy, advancing key compounds in its pipeline, and leveraging global market strategies to grow market share and expand geographic presence.   Read More »
May 26, 2011
PharmaNet Development Group’s subsidiary, PharmaNet Canada, Inc. and Maisonneuve-Rosemont Hospital (HMR) and its Research Center, have agreed to collaborate in the conduct of pharmacokinetic studies in patients with impaired renal function.   Read More »
May 26, 2011
Labtec GmbH, a subsidiary of tesa SE, has opened its new GMP manufacturing facility for transdermal drug delivery systems (TDS) and oral dispersible films (ODF) employing its RapidFilm technology.   Read More »
May 25, 2011
Industry vet Wes Wheeler named CEO of logistics co.  Read More »
May 25, 2011
Sixth milestone resulting from 2005 CNS pact  Read More »
May 25, 2011
Primary packaging site to provide ampoules and vials  Read More »
May 25, 2011
Alliance will aid clients in CNS discovery  Read More »
May 25, 2011
OliGO designed to streamline process knowledge  Read More »
May 25, 2011
Alliance will target neruodegenerative disorders  Read More »
May 24, 2011
Eli Lilly and Co. has signed agreements with private investors Care Capital and NovaQuest Capital to establish BioCritica, Inc., a new, privately held biotechnology company.  Read More »
May 24, 2011
ICON has launched cytometry services from its Central Laboratories business unit to support the testing requirements and development phase of compounds.   Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On